Top 20 pharma accelerates training and enrollment across 650 Site Staff

A top-20 pharmaceutical company was planning a large Phase III trial of a new vaccine for a mosquitoborne viral disease. Stakes were exceptionally high due to the scope of the trial, seasonal nature of the disease, and competitive pressures.

The success of the trial required rapid training and onboarding of all trial sites to ensure their readiness to enroll patients during the rainy season. Advarra
Study Startup was used to provide training for every staff member at every trial site, inclusive of real-time training reports, helping to ensure that all 20,000 patients enrolled were treated exactly according to protocol.